ASX - By Stock
|
IMM |
Re:
Ann: CHDR to conduct first-in-human phase 1 trial of IMP761
|
|
QuanQuest
|
10 |
3.2K |
16 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
10
|
3.2K
|
16
|
|
ASX - By Stock
|
HZR Technology |
Re:
100 hours please
|
|
QuanQuest
|
83 |
23K |
13 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
83
|
23K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FDA Grants PharmAust Pre-IND Meeting
|
|
QuanQuest
|
61 |
16K |
12 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
61
|
16K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: PAA completes Phase 1 and files for Orphan Drug Designation
|
|
QuanQuest
|
430 |
106K |
6 |
19/12/23 |
19/12/23 |
ASX - By Stock
|
430
|
106K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Only a matter of time
|
|
QuanQuest
|
19 |
10K |
10 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
19
|
10K
|
10
|
|
ASX - By Stock
|
HZR |
Re:
Ann: CDP Commissioning Underway After Successful Reactor Install
|
|
QuanQuest
|
144 |
44K |
2 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
144
|
44K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
QuanQuest
|
87 |
18K |
22 |
11/12/23 |
11/12/23 |
ASX - By Stock
|
87
|
18K
|
22
|
|
ASX - By Stock
|
HZR |
Re:
Ann: CDP Commissioning Underway After Successful Reactor Install
|
|
QuanQuest
|
144 |
44K |
4 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
144
|
44K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: New Hires & Attendance at International MND Symposium
|
|
QuanQuest
|
56 |
12K |
19 |
07/12/23 |
07/12/23 |
ASX - By Stock
|
56
|
12K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Ann: New Hires & Attendance at International MND Symposium
|
|
QuanQuest
|
56 |
12K |
15 |
06/12/23 |
06/12/23 |
ASX - By Stock
|
56
|
12K
|
15
|
|
ASX - By Stock
|
HZR |
Re:
Ann: HZR & Mitsui Agree to Advance Collaboration on HZR Graphite
|
|
QuanQuest
|
62 |
18K |
2 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
62
|
18K
|
2
|
|
ASX - By Stock
|
HZR |
Re:
Ann: HZR & Mitsui Agree to Advance Collaboration on HZR Graphite
|
|
QuanQuest
|
62 |
18K |
3 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
62
|
18K
|
3
|
|
ASX - By Stock
|
HZR |
Re:
Ann: HZR & Mitsui Agree to Advance Collaboration on HZR Graphite
|
|
QuanQuest
|
62 |
18K |
6 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
62
|
18K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
FDA Application for Orphan Drug Designation , PAA, MPL
|
|
QuanQuest
|
355 |
67K |
5 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
355
|
67K
|
5
|
|
ASX - By Stock
|
PAA Biotech |
Re:
FDA Application for Orphan Drug Designation , PAA, MPL
|
|
QuanQuest
|
355 |
67K |
8 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
355
|
67K
|
8
|
|
ASX - By Stock
|
PAA Biotech |
Re:
FDA Application for Orphan Drug Designation , PAA, MPL
|
|
QuanQuest
|
355 |
67K |
6 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
355
|
67K
|
6
|
|
ASX - By Stock
|
PAA Biotech |
Re:
FDA Application for Orphan Drug Designation , PAA, MPL
|
|
QuanQuest
|
355 |
67K |
10 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
355
|
67K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
FDA Application for Orphan Drug Designation , PAA, MPL
|
|
QuanQuest
|
355 |
67K |
13 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
355
|
67K
|
13
|
|
ASX - By Stock
|
PAA Biotech |
Re:
FDA Application for Orphan Drug Designation , PAA, MPL
|
|
QuanQuest
|
355 |
67K |
10 |
27/11/23 |
27/11/23 |
ASX - By Stock
|
355
|
67K
|
10
|
|
ASX - By Stock
|
PAA Biotech |
Re:
Full takeover versus multiple deals?
|
|
QuanQuest
|
76 |
13K |
14 |
16/11/23 |
16/11/23 |
ASX - By Stock
|
76
|
13K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
FDA Application for Orphan Drug Designation , PAA, MPL
|
|
QuanQuest
|
355 |
67K |
14 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
355
|
67K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
FDA Application for Orphan Drug Designation , PAA, MPL
|
|
QuanQuest
|
355 |
67K |
12 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
355
|
67K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
FDA Application for Orphan Drug Designation , PAA, MPL
|
|
QuanQuest
|
355 |
67K |
14 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
355
|
67K
|
14
|
|
ASX - By Stock
|
PAA Biotech |
Re:
FDA Application for Orphan Drug Designation , PAA, MPL
|
|
QuanQuest
|
355 |
67K |
16 |
13/11/23 |
13/11/23 |
ASX - By Stock
|
355
|
67K
|
16
|
|
ASX - By Stock
|
HZR |
Re:
Ann: CDP Drives Towards Start-Up As Reactor Fabrication Completed
|
|
QuanQuest
|
192 |
54K |
5 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
192
|
54K
|
5
|
|
ASX - By Stock
|
HZR |
Re:
Ann: CDP Drives Towards Start-Up As Reactor Fabrication Completed
|
|
QuanQuest
|
192 |
54K |
4 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
192
|
54K
|
4
|
|
ASX - By Stock
|
HZR |
Re:
Ann: CDP Drives Towards Start-Up As Reactor Fabrication Completed
|
|
QuanQuest
|
192 |
54K |
6 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
192
|
54K
|
6
|
|
ASX - By Stock
|
HZR |
Re:
Ann: HZR & Mitsui Agree to Advance Collaboration on HZR Graphite
|
|
QuanQuest
|
62 |
18K |
2 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
62
|
18K
|
2
|
|
ASX - By Stock
|
HZR |
Re:
Ann: HZR & Mitsui Agree to Advance Collaboration on HZR Graphite
|
|
QuanQuest
|
62 |
18K |
8 |
31/10/23 |
31/10/23 |
ASX - By Stock
|
62
|
18K
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
QuanQuest
|
2.6K |
1.0M |
3 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
QuanQuest
|
2.6K |
1.0M |
16 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
16
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
QuanQuest
|
2.6K |
1.0M |
20 |
25/10/23 |
25/10/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
20
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
QuanQuest
|
2.6K |
1.0M |
13 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
13
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
QuanQuest
|
2.6K |
1.0M |
14 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
14
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
QuanQuest
|
2.6K |
1.0M |
9 |
24/10/23 |
24/10/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Webcast slides for new Efti clinical data in 1st line NSCLC
|
|
QuanQuest
|
25 |
10K |
19 |
23/10/23 |
23/10/23 |
ASX - By Stock
|
25
|
10K
|
19
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Options Offer to Existing Listed Option Holders
|
|
QuanQuest
|
79 |
16K |
11 |
19/10/23 |
19/10/23 |
ASX - By Stock
|
79
|
16K
|
11
|
|
ASX - By Stock
|
COB Cobalt |
Re:
Broken Hill global cobalt province.
|
|
QuanQuest
|
1.0K |
953K |
0 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
1.0K
|
953K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Canine Trial Update
|
|
QuanQuest
|
126 |
28K |
11 |
25/09/23 |
25/09/23 |
ASX - By Stock
|
126
|
28K
|
11
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Commercial Scale Manufacturing of Efti for Clinical Trials
|
|
QuanQuest
|
29 |
12K |
11 |
24/09/23 |
24/09/23 |
ASX - By Stock
|
29
|
12K
|
11
|
|
ASX - By Stock
|
HZR |
Re:
Ann: CDP Reactor Completes Major Fabrication Milestone
|
|
QuanQuest
|
124 |
36K |
2 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
124
|
36K
|
2
|
|
ASX - By Stock
|
HZR |
Re:
Ann: CDP Reactor Completes Major Fabrication Milestone
|
|
QuanQuest
|
124 |
36K |
0 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
124
|
36K
|
0
|
|
ASX - By Stock
|
HZR |
Re:
Ann: CDP Reactor Completes Major Fabrication Milestone
|
|
QuanQuest
|
124 |
36K |
2 |
20/09/23 |
20/09/23 |
ASX - By Stock
|
124
|
36K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
QuanQuest
|
2.6K |
1.0M |
11 |
16/09/23 |
16/09/23 |
ASX - By Stock
|
2.6K
|
1.0M
|
11
|
|
ASX - By Stock
|
PAA Biotech |
Re:
PAA, The New Dawn, September , Optober 2023
|
|
QuanQuest
|
132 |
32K |
7 |
15/09/23 |
15/09/23 |
ASX - By Stock
|
132
|
32K
|
7
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Additional Phase 1 data suggest MPL may inhibit MND
|
|
QuanQuest
|
380 |
83K |
14 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
380
|
83K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Additional Phase 1 data suggest MPL may inhibit MND
|
|
QuanQuest
|
380 |
83K |
13 |
12/09/23 |
12/09/23 |
ASX - By Stock
|
380
|
83K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Additional Phase 1 data suggest MPL may inhibit MND
|
|
QuanQuest
|
380 |
83K |
14 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
380
|
83K
|
14
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Additional Phase 1 data suggest MPL may inhibit MND
|
|
QuanQuest
|
380 |
83K |
17 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
380
|
83K
|
17
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Chief Executive Officer Appointment
|
|
QuanQuest
|
95 |
21K |
15 |
28/08/23 |
28/08/23 |
ASX - By Stock
|
95
|
21K
|
15
|
|